Edition:
United States

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

22.70USD
18 Oct 2018
Change (% chg)

-- (--)
Prev Close
$22.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
664,221
52-wk High
$27.32
52-wk Low
$8.68

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.39 -0.655
Mar '18 0.48 -0.214
Dec 0.60 -0.016
Sep 0.69 -0.811
FY 2017 Jun '17 0.64 -0.485
Mar '17 1.32 -0.550
Dec 0.38 -0.234
Sep 0.74 -0.169
FY 2016 Jun '16 0.93 -0.167
Mar '16 0.90 -0.148
Dec 0.67 -0.145
Sep 0.73 -0.163
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 4.27 12.70 0.00 --
Quarter Ending Sep-19 1 22.80 22.80 22.80 --
Year Ending Jun-18 4 5.15 14.40 1.80 --
Year Ending Jun-19 5 35.63 58.30 7.00 35.60
Year Ending Jun-20 6 141.57 195.40 91.20 126.85
Earnings (per share)
Quarter Ending Jun-18 4 -0.22 -0.05 -0.31 --
Quarter Ending Sep-19 2 -0.24 -0.09 -0.39 --
Year Ending Jun-18 3 -1.26 -1.24 -1.29 --
Year Ending Jun-19 6 -1.09 -0.43 -1.56 -0.26
Year Ending Jun-20 6 -0.86 -0.23 -1.50 -0.49
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta 2.25 0.63 0.87
Price to Sales (TTM) 1,733.14 109.82 6.55
Price to Book (MRQ) 9.33 13.72 4.00
Price to Tangible Book (MRQ) 9.33 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -39.86 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago -30.25 91.25 6.56
Sales - 5 Yr. Growth Rate -15.36 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago -35.23 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago -18.04 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate 75.72 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 14.82 1.65 2.22
Current Ratio (MRQ) 14.82 5.52 2.99
LT Debt to Equity (MRQ) 4.93 15.33 11.31
Total Debt to Equity (MRQ) 4.93 18.80 14.15
Interest Coverage (TTM) -15.75 -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.54 32.64 54.36
Gross Margin - 5 Yr. Avg. 82.53 52.76 53.16
EBITD Margin (TTM) -6,481.91 -- --
EBITD - 5 Yr. Avg -1,540.00 -164.07 16.13
Operating Margin (TTM) -7,145.30 -618.88 3.36
Operating Margin - 5 Yr. Avg. -1,557.72 -178.92 11.28
Pre-Tax Margin (TTM) -12,696.25 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -2,480.04 -181.48 11.54
Net Profit Margin (TTM) -12,703.48 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -2,459.28 -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 11,654 24,741,437 725,680,242
Net Income/Employee (TTM) -1,480,470 1,102,410 84,001,075
Receivable Turnover (TTM) 8.07 4.18 5.06
Inventory Turnover (TTM) 2.12 2.14 3.65
Asset Turnover (TTM) 0.01 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.26 0.35 9.83
Return on Assets - 5 Yr. Avg. -78.20 3.11 10.94
Return on Investment (TTM) -82.70 1.96 12.83
Return on Investment - 5 Yr. Avg. -103.64 2.91 14.05
Return on Equity (TTM) -160.23 1.12 14.95
Return on Equity - 5 Yr. Avg. -406.03 -0.97 15.39
  1 Year 3 Year 5 Year
Sales % -30.25 -27.48 -15.36
EPS (TTM) % -21.74 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immunomedics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -19.09 -19.30 37 59
13 Week -18.17 -21.01 72 76
26 Week 38.31 25.30 99 56
52 Week 71.53 51.60 99 83
YTD 23.76 14.72 99 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.55%
# of Holders: 271
Total Shares Held: 150,502,115
3 Mo. Net Change: 896,170
# New Positions: 6
# Closed Positions: 1
# Increased Positions: 17
# Reduced Positions: 8
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.